Gout is a form of arthritis which can be intensely painful and it is caused by having sodium urate crystals in joints. The approval of febuxostat, a non-purine-analogue inhibitor of xanthine oxidase, by the European Medicines Agency and the US Food and Drug Administration heralds a new era in the treatment of gout. Surging adoption of these biologics because of their ability to produce powerful anti-inflammatory action is likely to drive the market during the forecast period.According to AMA, the market for Gout Therapeutics is expected to register a CAGR of 11.9% during the forecast period to 2024. This growth is primarily driven by Increasing Adoption of Newer Therapies and Surging Number of Geriatric Population Across the World.
Globally, a noticeable market trend is evident Growing Focus on Regenerative Medicines by Key Players. Major Players, such as Regeneron Pharmaceuticals (United States), CymaBay Therapeutics (United States), LG Life Sciences (South Korea), Eisai Co., Ltd. (Japan), Antares Pharma (United States), Boehringer Ingelheim (Germany), AstraZeneca (United Kingdom), Takeda Pharmaceuticals (Japan), GlaxoSmithKline (United Kingdom), Eli Lilly (United States), Merck & Co. (United States) and Novartis (Switzerland) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
In December 2015, AstraZeneca’s product, Zurampic (lesinurad), in combination with xanthine oxidase inhibitor (XOI) received an approval from the United States FDA to treat gout.
- Increasing Adoption of Newer Therapies
- Surging Number of Geriatric Population Across the World
- Growing Focus on Regenerative Medicines by Key Players
- Lack of Awareness in Developing Economies
Increased in Incidence and Prevalence of Gout in Developed Economies and Increasing Adoption of Biologics
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization of the Report:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase